Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment

J Zhang, H Tavakoli, L Ma, X Li, L Han, XJ Li - Advanced drug delivery …, 2022 - Elsevier
Cancer immunotherapy has achieved remarkable success over the past decade by
modulating patients' own immune systems and unleashing pre-existing immunity. However …
被引用次数：45 相关文章

Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment

J Zhang, H Tavakoli, L Ma, X Li, L Han… - Advanced Drug Delivery …, 2022 - par.nsf.gov
The tumor microenvironment (TME) promotes proliferation, drug resistance, and
invasiveness of cancer cells. Therapeutic targeting of the TME is an attractive strategy to …

Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment

J Zhang, H Tavakoli, L Ma, X Li, L Han, XJ Li - Advanced Drug Delivery …, 2022 - Elsevier
Cancer immunotherapy has achieved remarkable success over the past decade by
modulating patients' own immune systems and unleashing pre-existing immunity. However …

Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment

J Zhang, H Tavakoli, L Ma, X Li… - … drug delivery reviews, 2022 - pubmed.ncbi.nlm.nih.gov
Cancer immunotherapy has achieved remarkable success over the past decade by
modulating patients' own immune systems and unleashing pre-existing immunity. However …

Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.

J Zhang, H Tavakoli, L Ma, X Li, L Han - Advanced Drug Delivery …, 2022 - europepmc.org
Cancer immunotherapy has achieved remarkable success over the past decade by
modulating patients' own immune systems and unleashing pre-existing immunity. However …